Brain MRI abnormal findings | ||||
---|---|---|---|---|
Characteristics | Patients (N=53) | Absent (n=28) | Present (n=25) | p Value |
Gender (male/female) | 8/45 | 3/25 | 5/20 | 0.4527* |
Age (years) (mean±SD) | 38.9±17.1 | 35.1±17.2 | 43.1±16.3 | 0.0625† |
Disease duration (months) (mean±SD) | 47.1±90.3 | 19.8±55.2 | 76.4±111.4 | 0.0009† |
Follow-up period (months) (mean±SD) | 72.6±44.6 | 81.2±74.5 | 62.8±64.7 | 0.3312† |
Initial presentation of SLE | 33 (62.3%) | 21 (75.0%) | 12 (48.0%) | 0.0525† |
Mean of total BILAG-2004 index score | 14.2 | 14.6 | 13.9 | 0.6148† |
Neuropsychiatric manifestations | ||||
ACS | 37 | 17 | 20 | 0.1474* |
Psychosis | 6 | 5 | 1 | 0.1959* |
AD | 3 | 3 | 0 | 0.2380* |
MD | 12 | 7 | 5 | 0.7499* |
CD | 6 | 2 | 4 | 0.4042* |
Complication of seizures | 11 | 4 | 7 | 0.3126* |
Hypertension | 3 | 1 | 2 | 1.0000* |
Hyperlipidaemia | 0 | 0 | 0 | |
Diabetes mellitus | 3 | 2 | 1 | 1.0000* |
*Fisher's exact test.
†Mann-Whitney U test.
ACS, acute confusional state; AD, anxiety disorder; BILAG, British Isles Lupus Assessment Group; CD, cognitive dysfunction; MD, mood disorder; NPSLE, neuropsychiatric systemic lupus erythematosus; SLE, systemic lupus erythematosus.